TSH vs TRH: Two Steps of the Thyroid Axis

The short version

TRH and TSH are often mentioned together because they sit one step apart in the same regulatory chain, but they are chemically and anatomically distinct. Reviews of the hypothalamus pituitary thyroid axis describe TRH as a small peptide produced by neurons in the hypothalamus and TSH as a glycoprotein hormone produced by thyrotroph cells in the anterior pituitary, with TRH acting on the pituitary and TSH acting on the thyroid gland (PMID 27347897). The same literature describes thyroid hormones released from the thyroid as feeding back on both the hypothalamic and pituitary steps, which is what keeps the system within a range rather than running away in one direction (PMID 25905193).

This page is for educational purposes only and is not medical advice; consult a licensed physician for any question about thyroid symptoms, laboratory results or treatment. Nothing here is a protocol, and no dosing information is provided.

Where each one is made

Descriptions of the axis place the TRH producing neurons in the hypothalamic paraventricular region, with their nerve terminals releasing TRH into the hypophysial portal circulation that carries it a short distance to the anterior pituitary (PMID 27347897). That portal route matters for the comparison: TRH is described as reaching the pituitary in relatively high local concentration through a private vascular link rather than circulating widely through the body at the same concentration (PMID 25905193).

TSH, by contrast, is described as a systemic hormone. Thyrotrophs of the anterior pituitary secrete it into the general circulation, from which it reaches thyroid follicular cells and stimulates thyroid hormone synthesis and release (PMID 27347897). Because TSH travels in blood at concentrations that reflect pituitary output, reviews note that it is the measurable readout most often used in research on axis function (PMID 25005935).

Structure: a tripeptide versus a glycoprotein

The size difference is large. Endocrine physiology texts describe TRH as a tripeptide, a chain of only three amino acid residues with modified ends, generated by processing of a larger precursor protein (PMID 25905193). TSH is described as a heterodimeric glycoprotein built from an alpha subunit shared with other pituitary glycoprotein hormones and a beta subunit that gives TSH its specificity, with carbohydrate side chains attached to the protein core (PMID 25905193).

That structural distinction has downstream consequences described in the literature. Genetic reviews of central hypothyroidism report that mutations affecting the TSH beta subunit gene, the TRH receptor gene, or pituitary transcription factors required for thyrotroph development can each produce inadequate thyroid stimulation despite an intact thyroid gland (PMID 10800768). In other words, researchers have mapped separate failure points at the hypothalamic signal, the receptor that reads it, and the hormone that the pituitary builds in response (PMID 10800768).

Receptors: who reads each signal

Pharmacology reviews of the axis describe TRH acting through G protein coupled TRH receptors expressed on pituitary thyrotrophs, while TSH acts through the TSH receptor on thyroid follicular cells, a separate G protein coupled receptor in the glycoprotein hormone receptor family (PMID 38111381). The same review frames these receptors, along with thyroid hormone receptors and transporters, as distinct molecular targets that have been explored by researchers developing modulators of axis activity (PMID 38111381).

Because the two receptors sit on different cell types in different organs, a change at one level does not automatically mean the same change at the other. Reviews of axis physiology describe situations in which hypothalamic input, pituitary responsiveness and thyroid gland output move in different directions, which is why the literature treats TRH and TSH as two separate variables rather than interchangeable markers (PMID 27347897).

How TRH drives TSH release

In the standard description, TRH arriving at the thyrotroph binds its receptor and triggers an intracellular signalling cascade that increases transcription of the TSH subunit genes and promotes secretion of stored hormone (PMID 25905193). Reviews also describe TRH as influencing the glycosylation of TSH, so that hypothalamic input shapes not only how much TSH appears but also the biological activity of the molecules that are released (PMID 25905193).

Pharmacological work on the axis describes the TRH receptor as the entry point for this amplification step, converting a small peptide signal into secretion of a much larger hormone that then acts on a whole gland (PMID 38111381). The thyroid hormones produced as a result are described in a major physiological review as acting on essentially every tissue, with effects on basal metabolic rate, thermogenesis and substrate handling (PMID 24692351).

Feedback from thyroid hormones

Negative feedback is the feature that distinguishes a chain from a simple on switch. Reviews describe circulating thyroxine and triiodothyronine as suppressing both TRH gene expression in hypothalamic neurons and TSH output from thyrotrophs, with local conversion of thyroxine to the more active triiodothyronine inside the brain contributing to the sensing step (PMID 27347897). Because of this arrangement, measured TSH reflects the pituitary reading of thyroid hormone availability rather than hypothalamic drive alone (PMID 25905193).

The relationship is not a single fixed number for everyone. A review of axis regulation argued that the classical idea of one universal setpoint is incomplete, describing individual setpoints, non linear relationships between thyroid hormone and TSH concentrations, and influences such as age and physiological state (PMID 25005935). That review is a useful reminder that population reference intervals and individual regulation are different concepts (PMID 25005935).

Side by side comparison

The TRH stimulation test in published research

Because TRH is the natural stimulus for TSH release, investigators built a provocative test around it: administer TRH and measure the TSH response over time to probe pituitary reserve and responsiveness, a strategy described in physiological accounts of the axis (PMID 25905193). Reviews of central hypothyroidism describe such testing as historically used in efforts to separate pituitary level from hypothalamic level causes of inadequate thyroid stimulation, alongside genetic characterisation of the responsible mutations (PMID 10800768). No dosing details are given here, and the test is discussed only as a historical and research method, not as something a reader should pursue.

Sensitive immunoassays for TSH changed the practical value of the test, since baseline measurement alone answered many of the questions that provocation was once needed for, a shift consistent with the emphasis placed on measured TSH in modern discussions of axis regulation (PMID 25005935). A broader pharmacology review places TRH receptor agonism among the molecular approaches that researchers have examined when studying the axis experimentally (PMID 38111381).

When the axis shifts: illness, cold and medication

The TRH to TSH relationship is not fixed across all physiological states. A review of the axis in critical illness reported that acute and prolonged critical illness are associated with altered thyroid hormone concentrations and changes in central drive to the pituitary, so that TSH does not respond in the way it would in a healthy resting state (PMID 11800517). An update on accidental hypothermia described physiological changes across multiple organ systems in cooled subjects, including endocrine responses, illustrating that temperature and systemic stress sit alongside the classical feedback loop as influences on measurement (PMID 35280892).

Medication effects have also been reviewed. A review of the endocrine effects of antiepileptic drugs reported that several of these agents are associated with changes in thyroid hormone concentrations, which is one reason researchers interpret axis measurements in the context of concurrent drug exposure (PMID 19205363). Interpretation of any individual result belongs with a licensed physician, not with a general education page.

TSH outside the classical axis: seasonal biology

Comparative work has given TSH a second storyline that TRH does not share in the same way. Reviews of vertebrate seasonal reproduction describe TSH produced in the pars tuberalis of the pituitary acting locally on the mediobasal hypothalamus, where it changes deiodinase expression and local thyroid hormone availability, linking day length to reproductive activation (PMID 31406058). A review of photoperiodic regulation described this pathway as broadly conserved across vertebrate groups studied to date (PMID 30332291), and a comparative analysis reported shared mechanistic features of this seasonal signalling system across species (PMID 26050562).

TRH and TSH in research settings: what studies report

The verified literature summarised here consists of reviews of physiology, genetics, pharmacology and clinical states rather than safety trials of peptide administration, so no adverse event rates are quoted on this page. What researchers reported instead concerns regulation: that axis output varies with illness (PMID 11800517), that individual setpoints differ and complicate simple interpretation (PMID 25005935), and that genetic defects at several steps can disrupt the chain independently (PMID 10800768). Readers looking for safety data on any specific compound should look to trial reports of that compound rather than to physiological reviews.

Common points of confusion

• They are not the same molecule with different names. One is a tripeptide and the other is a two subunit glycoprotein (PMID 25905193).
• TSH does not act on the pituitary. TSH acts on thyroid follicular cells through the TSH receptor, while TRH acts on the pituitary (PMID 38111381).
• Measured TSH is a pituitary output, not a hypothalamic one. Reviews describe it as reflecting the pituitary reading of thyroid hormone exposure (PMID 27347897).
• Thyroid hormone effects are systemic. A physiological review described thyroid hormone action across metabolic tissues and energy expenditure (PMID 24692351).

Related reading

• TRH physiology: the hypothalamic tripeptide in detail
• TSH physiology: the pituitary glycoprotein in detail
• What the TSH blood test measures

References

• Hypothalamus-Pituitary-Thyroid Axis (Comprehensive Physiology, 2016)
• Physiology of the Hypothalamic-Pituitary-Thyroid Axis (2000)
• Receptor modulators associated with the hypothalamus-pituitary-thyroid axis (Frontiers in Pharmacology, 2023)
• Beyond the fixed setpoint of the hypothalamus-pituitary-thyroid axis (European Journal of Endocrinology, 2014)
• Thyroid hormone regulation of metabolism (Physiological Reviews, 2014)
• Genetic aspects of central hypothyroidism (Journal of Endocrinological Investigation, 2000)
• The hypothalamic-pituitary-thyroid axis in critical illness (Best Practice and Research Clinical Endocrinology and Metabolism, 2001)
• Physiological Changes in Subjects Exposed to Accidental Hypothermia: An Update (Frontiers in Medicine, 2022)
• Endocrine effects of antiepileptic drugs (Przeglad Lekarski, 2008)
• The underlying mechanisms of vertebrate seasonal reproduction (Proceedings of the Japan Academy Series B, 2019)
• Photoperiodic Regulation of Reproduction in Vertebrates (Annual Review of Animal Biosciences, 2019)
• Comparative analysis reveals the underlying mechanism of vertebrate seasonal reproduction (General and Comparative Endocrinology, 2016)